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Restenosis after coronary angioplasty is the single complication 
that most limits this revascularization procedure in clinical prac-
tice. The process is largely unprediCtable and the lesion-related 
factors predisposing to restenosis are poorly understood, with 
little consensus in published reports. In this study using detailed 
quantitative angiographic measurements to assess 490 lesions, the 
simple lesion characteristics associated with restenosis were de-
fined and the relation to the restenosis process documented. 
Restenosis was defined as an absolute deterioration in the minimal 
lumen diameter by 2::0.72 mm, a criterion based on the 95% 
confidence intervals for repeat angiographic measurements. This 
was chosen in an attempt to separate spurious changes due to a 
poor angiographic result and the variability of angiographic 
measurements from significant changes due to the restenosis 
process. 
The principal determinants of restenosis were found to be a 
large improvement in the minimal lumen diameter at the time of 
dilation (1.13 mm for the restenosis group compared with 
0.86 mm for the no restenosis group [p < 0.0001]) and an optimal 
Restenosis after angioplasty is conventionally determined by 
the angiographic restenosis rate. Although this is known to 
be an inaccurate reflection of "clinical restenosis" (1-6), it is 
the most objective and reproducible form of assessment and 
consequently it remains the index by which the long-term 
success of angioplasty (7-9) as well as other nonsurgical 
revascularization procedures is judged. 
This index, however, is significantly influenced not only 
by the definition of restenosis employed, but also by a host 
of other factors such as incomplete dilation, method of 
angiographic analysis, low follow-up rates and biased patient 
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postangioplasty result (minimal lumen diameter 2.28 mm in the 
restenosis group compared with 2.05 mm [p < 0.001] in the no 
restenosis group, corresponding to a 25% and a 30% diameter 
stenosis, respectively [p < 0.0001]). 
These observations reported for the first time suggest that the 
distinction needs to be made between a "clinical restenosis" of 
2::50% diameter stenosis and the "restenosis process" as mea-
sured by the absolute changes occurring during and after angio-
plasty. They lend support to the hypothesis that the degree of 
mechanical stretch produced by the dilating balloon on the vessel 
wall may be important in stimulating the restenosis prO<;ess. This 
is in contradiction to deductions obtained if restenosis is based on 
"clinical restenosis," which suggests that restenosis is associated 
primarily with a poor angioplasty result. More important, it 
indicates that there is potential for misinterpreting the results of 
restenosis studies if the observations are based solely on conven-
tional restenosis criteria without knowledge of the absolute 
changes occurring during and after the angioplasty procedure. 
(JAm Coli Cardio/1992;19:258-66) 
study groups. The failure to adopt a standard method of 
assessment has led to varying reports concerning the factors 
that influence the restenosis process. 
The current lack of information means that the optimal 
angioplasty result necessary to achieve good long-term suc-
cess is not known. Overdilation is associated with an in-
creased incidence of acute dissection (10) and may stimulate 
the re stenosis process by the extent of deep arterial injury, 
which in turn is associated with increased platelet activation 
(11). Alternatively, as suggested in the animal model (12), 
the injury due to stretching itself, independent of platelet 
accumulation, may be an important stimulant for restenosis. 
Conversely, underdilation may leave a significant residual 
stenosis, resulting in increased turbulence (5 ,13), increased 
platelet activation and subsequent restenosis by the same 
common pathway. More recently, the important association 
of residual stenosis, a positive stress test and their relation to 
"restenosis" have been reported (14). 
In this study, simple lesion variables (minimal lumen 
diameter, reference diameter and percent diameter stenosis) 
0735-1097/92/$5.00 
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Figure l. Single frame angiograms of a proximal left anterior descending 
artery stenosis before dilation (top left) , after dilation (top right) and at 
follow-up angiography (bottom). Quantitative coronary analysis was per-
formed using the Cardiovascular Angiography Analysis System. The arterial 
boundaries detected by the system are shown on the angiogram, and the 
diameter function curve derived from these contours is below. The example 
is chosen to illustrate a successfully dilated proximal left anterior artery 
lesion that undergoes a severe restenosis at 4 months. 
of risk of re stenosis for continuous variables is dependent on 
the arbitrary subdivision of data comparing the subgroup 
with the highest risk with the remainder of the study group. 
The risk may be artificially influenced b'y selecting small 
subgroups that vary from the population .b'y chance and do 
not reflect the true nature of the population they are drawn 
from. To define the groups, the data were classified into 
three groups according to convenient cutoff points, so that 
each group contained one-third of the overall study patients 
and the group with the highest restenosis rate was identified. 
The two remaining groups were then combined to form the 
group considered to be at "normal risk" and the odds ratio 
of restenosis determined by comparing the third of the 
patients in the high risk group with this reference group (the 
remaining two-thirds of the study patients). (The identifica-
tion of subgroups for postangioplasty percent diameter ste-
nosis is illustrated in Fig. 2.) This method of subdivision has 
the advantage of being consistent for all variables and thus 
avoids any bias in selection of subgroups that might be 
undertaken to emphasize a particular point. The 95% confi-
Figure 2. Frequency histograms grouped by percent diameter ste-
nosis after angioplasty showing how the group defined by the 
2:0.72-mm criterion is divided to determine a relevant odds ratio. 
The top line shows the number of lesions in each third of the group 
with restenosis (NO WITH REST). The vertical arrows with the 
values beneath show the points of subdivision. POST-PTCA = after 
coronary angioplasty . 
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Table 1. Clinical Characteristics of 424 Patients 
No. of lesions 
Lesions/patient 
Patient age (mean) (yr) 
Male/female ratio 
Time from angioplasty to follow-up (days) 
Vessels with CAD (no. of patients) 
I 
2 
3 
Previous CABG (no. of patients) 
Previous angioplasty (no. of patients) 
Previous MI (no. of patients) 
Dilated vessel (no. of patients) 
LAD 
LCx 
RCA 
Bypass graft 
No. of patients with more than one lesion 
dilated 
490 
1.16 
57 ± 9 (range 31 to 79) 
346/78 
94 ± 43 (range 3 to 226) 
288 (68%) 
97 (23%) 
39 (9%) 
31 (7%) 
176 (42%) 
44 (10%) 
239 (57%) 
80 (17%) 
97 (20%) 
10(2%) 
63 (15%) 
CABG = coronary artery bypass graft; LAD = left anterior descending 
coronary artery; LCx = left circumflex coronary artery ; MI = myocardial 
infarction; RCA = right coronary artery. 
were measured and the changes in each of these during and 
after the procedure assessed. The influence of the simple 
lesion morphology and changes occurring at angioplasty on 
the restenosis process have been determined and the distinc-
tion made between this process and " clinical restenosis" as 
assessed by more conventional restenosis criteria. 
Methods 
Study patients (Table 1). Five hundred consecutive pa-
tients who underwent successful angioplasty and agreed to 
have a follow-up angiogram were studied (7). Successful 
coronary angioplasty was defined as I) <50% diameter 
stenosis on visual inspection of the postangioplasty coronary 
angiogram performed in multiple views; and 2) no in-hospital 
complications (namely, recurrence of angina, coronary by-
pass grafting, repeat percutaneous transluminal coronary 
angioplasty, acute myocardial infarction or death). 
Patients with stable and unstable angina pectoris, as defined 
previously (15), were included. Patients with acute myocardial 
infarction receiving a thrombolytic agent who subsequently 
had immediate coronary angioplasty were excluded. 
Patients were allocated at a predetermined time for fol-
low-up angiography at the time of angioplasty. Of the 500 
patients who met the inclusion criteria, 424 patients (with 
490 lesions) had repeat angiograms suitable for quantitative 
analysis, with a mean time to follow-up angiography of 94 ± 
43 days. The reasons for failure to complete the study were 
late death (2 patients) , recatheterization contraindicated or 
refused (52 patients) and angiograms unsuitable for quanti-
tative analysis (22 patients). 
When clinically indicated (early recurrence of symp-
toms), patients were reinvestigated before the original preset 
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time. Table 1 shows the baseline characteristics of the 
patients included in the study. Data concerning patients 
followed-up within 4 months of angioplasty have previously 
been published (7). 
Coronary angioplasty. This was performed with a steer-
able, movable guide wire system by means of the femoral 
route. At the beginning of the angioplasty procedure, all 
patients received 10,000 IU of heparin and 500 mg of aspirin 
intravenously. After dilation, 10 mg of nifedipine was given 
orally every 2 h for the 1st 12 hand then 20 mg three times 
a day together with 500 mg of aspirin orally once a day until 
repeat angiography. 
Quantitative coronary angiography. The quantitative 
analysis of the stenotic coronary segments was carried out 
with the computer-assisted Cardiovascular Angiography 
Analysis System (CAAS), which has been described in detail 
(16, 17). Calibration of the diameter of the vessels in absolute 
values (mm) was achieved by using the guiding/diagnostic 
catheter as a scaling device (16). 
A representative series of analyses, with the detected 
contours and the diameter functions superimposed on the 
original video image, are shown in Figure 1. To standardize 
the measurements and minimize potential errors, the "inter-
polated" reference diameter measurement was used when-
ever possible. This method has the advantage of eliminating 
the arbitrary choice of a reference diameter that will vary 
among individual observers and provides a smoothing effect 
for the segments adjacent to the stenosis so that extreme 
irregularities in the vessel will not artificially bias the refer-
ence diameter measurement. It also reduces the effect of the 
change in reference diameter at follow-up angiography that 
occurs as part of the restenosis process (18). The principle 
behind this technique has previously been described (19-21) , 
as have the precision and overall accuracy of the system, the 
method of obtaining angiograms and precautions taken to 
reduce error (7). 
Restenosis criteria. The restenosis group was defined as 
those patients with a deterioration in the minimal lumen 
diameter from postangioplasty to follow-up of :::::0.72 mm, a 
criterion based on the 95% confidence limits for determining a 
significant change using a quantitative angiographic system 
(CAAS) (7, 16). The relevance of using this criterion and its 
comparison with the conventional cutoff criterion of ::::50% 
diameter stenosis at follow-up are addressed in the Discussion. 
Data analysis. All angiographic and procedural variables 
were entered into a relational data base and statistical 
analysis was performed with use of BMDP statistical soft-
ware (University of California, Berkeley, California, 1985). 
The tertile with the highest incidence of restenosis was 
identified for each variable , and the relative risk of restenosis 
in this group was compared with that in the remainder of the 
study group. An odds ratio for restenosis :::::2 with 95% 
confidence limits :::::1 was considered to have clinical rele-
vance in this study group. 
The variables selected for analysis in this study were all 
continuous with gaussian distributions. The determination 
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Table 2. Angiographic Variables of Restenosis Subgrouped According to Two Criteria 
250% Diameter Stenosis* 20.72 mmt 
No No 
Re stenosis Restenosis p Value Restenosis Restenosis p Value 
Minimal lumen diameter before angioplasty 1.18 1.21 NS 1.15 1.18 NS 
Minimal lumen diameter after angioplasty 2.02 2.10 NS 2.28 2.05 <0.001 
Minimal lumen diameter at follow-up 1.06 1.99 <0.0001 1.16 2.01 <0.0001 
% diameter stenosis before angioplasty 62.6 57.7 <0.01 58.8 58.3 NS 
% diameter stenosis after angioplasty 32.7 28.3 <0.005 24.8 29.7 <0.005 
% diameter stenosis at follow-up 64 29.1 <0.0001 54.3 29.7 <0.0001 
Normal vessel diameter before angioplasty 2.95 2.8 NS 2.86 2.85 NS 
Normal vessel diameter after angioplasty 3.05 2.94 NS 3.06 2.93 NS 
Normal vessel diameter at follow-up 2.92 2.81 NS 2.60 2.93 <0.001 
Change in minimal lumen diameter at angioplasty (mm) 0.93 0.91 NS 1.13 0.86 <0.0001 
Change in % diameter stenosis at angioplasty 30 29.4 NS 34 28.6 <0.01 
Change in minimal lumen diameter at follow-up (mm) 0.97 0.10 <0.0001 1.12 0.04 <0.0001 
Change in % diameter stenosis at follow-up 31.2 0.77 <0.0001 29.7 0.07 <0.0001 
*Criterion of 2'=50% diameter stenosis at follow-up angiography. tDeterioration in minimal lumen diameter by 20.72 mm after angioplasty to follow-up. 
dence intervals then provide an index of the degree of 
certainty for the result obtained. 
Results 
Pre- and postangioplasty coronary stenosis measurements. 
For the total study group, the mean minimal lumen diameter 
was 1.18 mm before angioplasty, 2.09 mm after angioplasty 
and 1.85 mm at follow-up. The corresponding mean refer-
ence diameters were 2.85, 2.96 and 2.83 mm, giving rise to a 
percent diameter stenosis of 58.4% before angioplasty, 
28.9% after angioplasty and 33.9% at follow-up. 
The mean values for the angiographic variables sub-
Table 3. Angiographic Variables Before Angioplasty 
Grouped by 20.72-mm Change Criterion 
grouped according to the :::::0.72-mm criterion and the :::::50% 
diameter stenosis criterion are shown in Table 2, emphasiz-
ing the differences between the two criteria. The grouping of 
the data for statistical analysis, showing the numbers in each 
group and the odds ratio for restenosis, are shown in Tables 
3 to 5, again comparing the values obtained using the 
:::::0.72-mm criterion with the :::::50% diameter stenosis crite-
rion. 
Preangioplasty variables predictive of restenosis (Table 3). 
None of the preangioplasty variables were found to be 
associated with restenosis. A severe >65% diameter steno-
sis before angioplasty was the most relevant factor, with an 
odds ratio of 1.63 and confidence intervals from 0.85 to 3.31. 
Grouped by 250% Diameter Stenosis 
Minimal Lumen Diameter Before Angioplasty 
No restenosis 
Restenosis 
Total 
Odds ratio= 1.29 (0.76-2.19) 
No restenosis 
Restenosis 
Total 
Odds ratio = 1.63 (0.85-3.13) 
No restenosis 
Restenosis 
Total 
Odds ratio = 1.09 (0.64-1.86) 
:SI mm 
129 (85) 
22 (15) 
151 
:S65% 
312 (85) 
57 (16) 
370 
:s3.2 mm 
289 (84) 
57 (16) 
346 
>!mm 
278 (82) 
61 (18) 
339 
Total 
407 (83) 
83 (17) 
490 
No restenosis 
Restenosis 
Total 
Odds ratio = 1.21 (0.70-2.08) 
% Diameter Stenosis Before Angioplasty 
>65% 
94 (78) 
26 (22) 
120 
Total 
407 (83) 
83 (17) 
490 
No restenosis 
Restenosis 
Total 
Odds ratio = 1.42 (0.82-2.54) 
Normal Diameter Before Angioplasty 
>3.2 mm Total 
107 (82) 396 (83) No restenosis 
23 (18) 80 (17) Restenosis 
130 476 Total 
Odds ratio = 1.15 (0.64-2.04) 
:S!mm 
128 (85) 
23 (15) 
!51 
:S65% 
328 (89) 
42 (11) 
370 
:s3.2 mm 
301 (87) 
45 (13) 
346 
>!mm 
295 (87) 
44 (13) 
339 
>65% 
95 (79) 
25 (21) 
120 
>3.2 mm 
Ill (85) 
19 (15) 
130 
Total 
423 (86) 
67 (13) 
490 
Total 
423 (86) 
67 (14)" 
490 
Total 
412 (87) 
64 (13) 
476 
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Table 4. Angiographic Variables After Angioplasty 
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Grouped by ~50% Diameter Stenosis Criterion 
Minimal Lumen Diameter After Angioplasty 
No restenosis 
Restenosis 
Total 
Odds ratio= 2.88 (1.77-4.68) 
~2.3 mm 
304 (86) 
42 (14) 
346 
>2.3 mm 
103 (72) 
41 (28) 
144 
Total 
107 (83) 
83 (17) 
490 
No restenosis 
Restenosis 
Total 
Odds ratio = 0.28 (0.13-0.60) 
<2.3 mm 
285 (71) 
119 (29) 
404 
>2.3 mm 
77 (89) 
9 (11) 
86 
Total 
362 (74) 
128 (26) 
490 
% Diameter Stenosis After Angioplasty 
No restenosis 
Restenosis 
Total 
Odds ratio = 2.60 (1.40-4.82) 
~25% 
139 (75) 
47 (25) 
186 
>25% 
288 (89) 
36 (11) 
324 
Total 
407 (83) 
83 (17) 
490 
No restenosis 
Restenosis 
Total 
Odds ratio= 0.51 (0.28-0.95) 
~25% 
168 (81) 
17 (9) 
185 
>25% 
254 (80) 
50 (20) 
304 
Total 
422 (86) 
67 (14) 
490 
Normal Diameter After Angioplasty 
No restenosis 
Restenosis 
Total 
Odds ratio = 2.04 (1.25-3.31) 
~3.2 mm 
295 (86) 
47 (14) 
342 
>3.2 mm 
112 (76) 
36 (24) 
148 
Total 
407 (83) 
83 (17) 
490 
Postangioplasty variables predictive of restenosis (Table 4). 
The restenosis group had a significantly better postangio-
plasty result as judged by minimal lumen diameter (2.28 mm) 
and percent diameter stenosis (24.8%) compared with the no 
restenosis group (2.05 mm and 29.7%; p < 0.001 and p < 
0.0001, respectively). A postangioplasty minimal lumen di-
ameter > 2.3 mm was significantly associated with restenosis 
(odds ratio = 2.88) as was a postangioplasty percent diam-
eter stenosis :::;25% (odds ratio = 2.60). A vessel :::=3.2 mm in 
diameter was less clearly predisposed to restenosis accord-
ing to the :::=0. 72-mm criterion with an odds ratio of 2.04. 
Changes at angioplasty (Table 5). The factor most asso-
ciated with restenosis was a large change in the minimal 
lumen diameter at angioplasty: 1.13 mm for the restenosis 
group and 0.86 mm for the no restenosis group (p < 0.0001), 
which corresponds to a change in percent diameter stenosis 
of 34% and 28.6%, respectively. The risk associated with a 
large improvement in the stenosis in terms of descend-
ing order of magnitude were: minimal lumen diameter 
:::=1.14 mm, minimal lumen diameter adjusted for vessel size 
:::=0.35 mm and percent diameter stenosis :::=35%, giving odds 
ratios of 3.30, 2.98 and 2.20, respectively. There was also a 
trend for a large change in reference diameter >0.36 mm to 
be associated with an increased risk ofrestenosis (:::=0.72-mm 
criterion) with an odds ratio of 1.83. 
Discussion 
Criteria for postangioplasty restenosis. Soon after the 
introduction of coronary angioplasty as a revascularization 
procedure, it became clear that restenosis after the proce-
No restenosis 
Restenosis 
Total 
Odds ratio = 1.58 (0. 92-2.69) 
~3.2 mm 
301 (88) 
41 (12) 
342 
>3.2 mm 
122 (83) 
26 (18) 
148 
Total 
423 (86) 
67 (14) 
490 
dure was a significant limitation (22,23) and with the im-
provement in acute results over the years, this limitation has 
assumed increasing significance. Despite intensive investi-
gation, there is as yet no known intervention that is able to 
reduce the incidence of restenosis. The reported risk factors 
associated with restenosis are unsatisfactorily documented, 
with little agreement among the various studies. These 
differences are primarily due to the failure of investigators to 
adopt a suitable standardized methodology with a uniformly 
accepted definition of restenosis that is relevant to the 
restenosis process. It has frequently been pointed out that 
different restenosis criteria give rise to similar restenosis 
rates (5,24). Although this is true, these similar restenosis 
rates do not define the same groups of patients (with some-
times as little as 50% overlap) and therefore risk factors may 
well be very different for different restenosis criteria (7). 
Figure 3 illustrates the distribution of the two restenosis 
groups in relation to the total number of lesions studied. Of 
the 104 lesions fulfilling at least one of the two criteria (21% 
of the total group of 490 lesions) <50% fulfilled both criteria, 
and 24% and 33%, respectively, fulfilled the :::=50% diameter 
stenosis and the :::=0. 72-mm criteria. 
Risk factors for restenosis. There are as yet no prospec-
tive studies using quantitative coronary angiography that 
report on the risk factors for restenosis in large numbers of 
patients. However, a small number of factors relating to the 
restenosis process have been identified and confirmed in 
more than one study. These include dilation of a proximal 
left anterior descending coronary artery stenosis (5,25), a 
totally occluded vessel before angioplasty (26) and the 
presence of collateral vessels supplying the distal part of the 
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Table 5. Angiographic Variables: Change at Angioplasty 
Grouped by ;o:0.72-mm Change Criterion Grouped by ;o:50% Diameter Stenosis Criterion 
Change in Minimal Lumen Diameter at Angioplasty 
:s 1.14 >1.14 Total :SI.14 >1.14 Total 
No restenosis 314 (88) 93 (69) 407 (83) No restenosis 308 (85) 115 (86) 423 (86) 
Restenosis 42 (12) 41 (31) 83 (17) Restenosis 48 (15) 19 (14) 67 (14) 
Total 366 134 490 Total 356 134 490 
Odds ratio = 3.30 (2.02-5.37) Odds ratio = 1.06 (0.60-1.88) 
Adjusted Change in Minimal Lumen Diameter at Angioplasty 
:50.35 >0.35 Total :S0.35 >0.35 Total 
No restenosis 260 (89) 147 (74) 407 (83) No restenosis 115 (89) 243 (86) 358 (86) 
Restenosis 31 (11) 52 (26) 83 (17) Restenosis 23 (14) 44 (14) 67 (14) 
Total 291 199 490 Total 178 284 490 
Odds ratio = 2.98 (1.82-4.84) Odds ratio = 0.40 (0.22-0.76) 
Change in Diameter Stenosis at Angioplasty 
:s35% >35 Total :s35% >35% Total 
No restenosis 290 (75) 117 (75) 407 (83) No restenosis 288 (75) 135 (87) 423 (86) 
Restenosis 44 (25) 39 (25) 83 (17) Restenosis 46 (25) 21 (13) 67 (14) 
Total 234 156 490 Total 334 156 490 
Odds ratio = 2.20 (1.36-3.56) Odds ratio = 0.98 (0.67-1.70) 
Differences in Reference Diameter at Angioplasty 
:50.36 >0.36 Total 
No restenosis 320 (85) 75 (76) 395 (83) 
Restenosis 56 (15) 24 (24) 80 (17) 
Total 376 99 475 
Odds ratio= 1.83 (1.07-3.14) 
dilated coronary artery (27 ,28). The most frequently identi-
fied risk factor for restenosis has been incomplete dilation or 
a variable directly related to a poor angioplasty result, such 
as a residual pressure gradient (5,9). In our study, a reste-
nosis criterion that is dependent solely on the changes 
occurring after angioplasty was chosen to avoid having the 
results influenced by factors other than the restenosis pro-
cess. The distinction between the restenosis process and a 
suboptimal result has been made by comparing the 
Figure 3. Of the 490 lesions analyzed, 386 were free of restenosis 
and 104lesions (21%) had restenosis by either of the two criteria for 
restenosis. The column (right) illustrates how each criterion is 
associated with a substantial proportion of lesions that are exclusive 
to that criterion, with <50% of the lesions (43%) fulfilling both 
criteria. A similar lack of correlation exists with other convention-
ally used restenosis criteria. DS = diameter stenosis. 
Total Population Restenosls 
>509;0S 
- 249; 
! 0.72 nvn 
339; 
Bolh crllerla 
439; 
:50.36 >0.36 Total 
No restenosis 327 (87) 84 (84) 411 (86) 
Restenosis 49 (13) 15 (15) 64 (14) 
Total 376 99 475 
Odds ratio = 1.19 (0.64-2.23) 
2:0.72-mm criterion with that of 2:50% diameter stenosis. 
The analysis has been limited to the simple pre- and postan-
gioplasty morphology (minimal lumen diameter, reference 
diameter and percent diameter stenosis) and the changes 
occurring during the procedure. Analysis of data in this form 
represents a significant change from the convention and 
gives rise to conclusions that are at odds with some of those 
previously published. 
Pred.ilation variables. Of the predilation variables analyzed, 
only the severity of the initial lesion has previously been 
reported (9) to be associated with restenosis although many 
studies have failed to find this association. Other predilation 
variables not analyzed in this study, such as eccentricity, bend 
point location and proximal left anterior descending artery 
stenosis, presence of collateral vessels and a totally occluded 
artery, have also been implicated (5,24,29). 
The initial stenosis severity (Fig. 4) was not found to be 
associated with an increased risk as assessed with either of 
the two criteria: odds ratios = 1.29 and 1.21 when using the 
2:0.72-mm criterion and the 2:50% diameter stenosis crite-
rion, respectively. Likewise, if the severity of the initial 
stenosis is expressed as a percent of the normal diameter, a 
severe initial stenosis >65% was not significantly associated 
with an increased risk and this observation is in broad 
agreement with most published reports. 
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Figure 4. Odds ratios and 95% confidence intervals for restenosis in 
the third of the study group at highest risk are shown for the 
2=0.72-mm criterion (bold lines) and for comparison the correspond-
ing group according to the 2=50% diameter stenosis (fine lines) . The 
cutoff point defining the relevant group at highest risk is indicated. 
CHANGE MIN LUMINAL DIAM (adjusted)= change in minimal 
lumen diameter divided by normal diameter of vessel; DIAM = 
diameter; MIN = minimal; other abbreviations as in Figure 2. 
Postdilation variables. A poor postangioplasty result (or 
incomplete dilation) and factors associated with incomplete 
dilation such as a residual pressure gradient are most fre-
quently reported to be associated with restenosis. The data 
from this study show that the associated risk is highly 
dependent on the restenosis criterion employed: essentially 
a good result ( <25% diameter stenosis) is associated with 
restenosis if the 2:::0.72-mm criterion is used and, conversely, 
a suboptimal result (> 35% diameter stenosis) is a risk factor 
if 2:::50% diameter stenosis is used (Fig. 4) . 
It is, perhaps, not surprising that incomplete dilation 
should be identified as a risk factor if the criterion for 
restenosis is a 2:::50% diameter stenosis . However, the ques-
tion remains as to whether a more severe residual stenosis 
actually induces the restenosis process or whether it reflects 
the use of a restenosis criterion that preselects lesions with 
less than optimal results. The answer to this question is 
crucial because some theories addressing the cause of re ste-
nosis incorporate this concept but, more important, if this 
question is not critically addressed, studies that are designed 
to determine the effect of therapeutic interventions on re ste-
nosis may be falsely interpreted. 
Our study suggests that the latter of these two possibili-
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Figure S. Frequency histogram of 490 lesions after successful an-
gioplasty (POST-PTCA) grouped according to the postangioplasty 
percent diameter stenosis (DS). The distribution for the total study 
group is "normal" about a mean value of 29%. The lesions fulfilling 
each of the two criteria are also shown and the discrepancy between 
their distributions is clearly demonstrated: The group defined by the 
2=0.72-mm criterion is distributed around a mean value of 25% and 
the group defined by the 2=50% diameter stenosis criterion is 
distributed around a mean value of 32%. 
ties is the more likely and the frequency histogram (Fig. 5) 
illustrates why the discrepancy occurs, showing the distri-
bution of the two restenosis groups. The lesions with reste-
nosis (2=50% diameter stenosis criterion) tend to lie near the 
50% threshold immediately after the procedure. It seems 
that if a "cut-off'' criterion is used to define re stenosis, it will 
preselect those lesions that lie close to the cut-off value and 
this appears to be the most relevant factor for the 2:::50% 
diameter stenosis criterion. The reason for this is twofold. 
First, it should be remembered that the variability of the 
measurement using a quantitative measuring system is in the 
region of 6.5% (95% confidence limits ± 13%) (16), which 
suggests that if a ;::::50% criterion is used, a significant 
number of lesions will be defined as restenosis due to 
methodologic limitations of the measurement system, when 
in reality no change has taken place between angioplasty and 
follow-up. The potential for this type of error will be 
magnified many times if visual estimates for stenosis severity 
are used. Lesions with a better postangioplasty result will 
fall outside this error of measurement and therefore will not 
be falsely defined as restenosis due to methodologic limita-
tions. Second, after angioplasty, most lesions deteriorate to 
some extent (30), with the patients showing a normal distri-
bution around a mean deterioration of -0.22 mm; thus, if a 
deterioration in the lumen diameter is an integral part of the 
healing process, any "cut-off'' criterion that lies in the 
direction of population shift can be expected to choose 
preferentially those lesions near to the "cut-off'' point. 
Conversely, the lesions that meet the 2:::0.72-mm criterion 
tend to be distributed at the opposite end of the histogram 
and as a group have a much better result than those selected 
by the 2:::50% diameter stenosis criterion. The mean postan-
gioplasty percent diameter stenosis in this study was 25% for 
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those lesions fulfilling the ~0.72-mm criterion and 32% for 
the ~50% diameter stenosis criterion. 
Variables of change at angioplasty. The factors found to 
be associated with an increased risk according to the 
~0.72-mm criterion in ascending order were change in 
reference diameter, change in diameter stenosis, change in 
minimal lumen diameter and change in minimal lumen diam-
eter adjusted for vessel size by dividing by the normal 
diameter of the vessel (Fig. 4). It is clear that the more the 
lesion is improved at the time of the angioplasty procedure, 
the greater the subsequent deterioration in the months after 
the procedure. As one might expect, lesions that are im-
proved less than the norm tended to have a greater residual 
stenosis after angioplasty. These lesions, although likely to 
meet the ~50% diameter stenosis criterion because they lie 
close to it after angioplasty, undergo less deterioration than 
lesions that have a better result. The distinction should 
therefore be made between the postangioplasty result and 
the change in lumen diameter at angioplasty. Although the 
postangioplasty result is highly relevant to the long-term 
outcome, it is the change occurring at angioplasty that is the 
strongest predictor of subsequent deterioration between 
angioplasty and follow-up. This observation, which previ-
ously has not been generally recognized, is not entirely 
without rationale (10-14). 
Substantial improvements in lumen diameter during an-
gioplasty (from a severe stenosis to an optimal result) imply 
dispersion of large amounts of plaque into the vessel wall or 
alternatively a deeper dissection into the arterial wall to 
achieve the same effect. In either case, the degree of 
improvement is likely to correlate with the degree of trauma 
to the vessel wall. If the re stenosis process is influenced by 
the degree of trauma, then the greater and deeper the 
trauma, the more the restenosis process will be stimulated. 
These results suggest that those lesions that are likely to 
experience the largest deterioration after dilation are those 
severe initial lesions that have the optimal postangioplasty 
result. The frequency histogram (Fig. 6) of change in mini-
mal lumen diameter for the total study group and for those 
with restenosis according to the two criteria illustrates the 
discrepancy and relevance of the two criteria. 
Implications for clinical practice. There seems to be a 
consensus among clinicians that the better the result at 
angioplasty, the less chance there is of restenosis. This 
premise is not supported by hard experimental evidence, 
although clearly if the lesion is not effectively dilated, the 
long-term result cannot be expected to be good. The data 
from this study suggest that there may well be a compromise 
result somewhere between a 20% and 30% postangioplasty 
diameter stenosis that has a good chance of a satisfactory 
long-term result and may avoid the increased risk of acute 
dissection and occlusion (9) incurred by using an oversized 
balloon to achieve an optimal result. 
Perhaps more important, the postangioplasty result has 
implications for clinical restenosis studies, particularly when 
assessing the affect of pharmacologic interventions. If the 
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Figure 6. Frequency histogram similar to that in Figure 5 grouped 
according to change in minimal lumen diameter at angioplasty 
(PTCA). Again, the distribution is "normal," but with askew to the 
right. According to the :::::0.72-mm criterion, the lesions in the third 
of the group with the largest improvement in the minimal lumen 
diameter at angioplasty (n = 44) have the highest risk of re stenosis. 
DS = diameter stenosis. 
criterion of a ~50% diameter stenosis is used as the sole 
definition of restenosis, the preselection of poor postangio-
plasty results by this criterion may be of such influence that 
any effect produced by pharmacologic intervention may not 
be realized by statistical hypothesis testing. More subtly, as 
the lesions that fulfill the ~50% diameter stenosis criterion 
undergo less change between angioplasty and follow-up, it 
will become statistically difficult to show the effect of a truly 
beneficial agent because of inadequate statistical power-a 
verdict of "no benefit" being returned when in fact a benefit 
exists. It is interesting to note that almost universally the 
conclusions from these studies have been that no agent has 
a beneficial effect on restenosis. 
The use of restenosis criteria alone for assessing the 
long-term results of coronary angioplasty has the potential 
for producing misleading results. A distinction should be 
made between the postangioplasty result and the restenosis 
process as measured by the change in minimal lumen diam-
eter or minimal lumen area after the procedure. 
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